Logo of The Journal of Bone & Joint Surgery (Br)
Quick search:        
          Advanced Search
Guest Access | Sign In
Journal of Bone and Joint Surgery - British Volume, Vol 84-B, Issue 3, 344-350.
doi: 10.1302/0301-620X.84B3.12372  
Copyright © 2002 by British Editorial Society of Bone and Joint Surgery
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warwick, D.
Right arrow Articles by Thornton, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warwick, D.
Right arrow Articles by Thornton, M.

A randomised comparison of a foot pump and low-molecular-weight heparin in the prevention of deep-vein thrombosis after total knee replacement

D. Warwick, MD, FRCS, FRCS Orth, Consultant Hand Orthopaedic Surgeon

Southampton University Hospitals, Tremona Road, Southampton SO16 6YD, UK.

J. Harrison, BSc, PhD, MRPharmS, DipClinPharm, Senior Clinical Pharmacist

North Staffordshire Hospitals, Newcastle Road, Stoke-on-Trent ST4 6QG, UK.

S. Whitehouse, BSc, Research Associate

Department of Orthopaedics

A. Mitchelmore, FRCR, Consultant Radiologist; and M. Thornton, MRCP, FRCR, Consultant Radiologist

Department of Radiology, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.

Correspondence should be sent to Mr D. Warwick.

Patients who undergo total knee replacement (TKR)are at high risk of venous thromboembolism. Low-molecular-weight heparins (LMWH) are the most suitable chemical prophylactic agents but there are some uncertainties about their safety and effectiveness. The foot pump offers an alternative.

We randomised 229 patients undergoing primary, unilateral TKR to receive either the A-V Impulse foot pump or enoxaparin, a LMWH. Ascending venography was undertaken between the sixth and eighth postoperative day in 188 patients without knowledge of the randomisation category. The prevalence of venographic deep-vein thrombosis was 58% (57/99) in the foot-pump group and 54% (48/89) in the LMWH group which was not statistically significant. There were four cases of proximal thrombi and two of fatal pulmonary emboli in the foot-pump group and none in the LMWH group. There were fewer haemorrhagic complications and soft-tissue effects in the foot-pump group.

We conclude that the neither method provides superior prophylaxis.




This article has been cited by other articles:


Home page
J Bone Joint Surg BrHome page
S. Fuchs, T. Heyse, G. Rudofsky, G. Gosheger, and C. Chylarecki
Continuous passive motion in the prevention of deep-vein thrombosis: A RANDOMISED COMPARISON IN TRAUMA PATIENTS
J Bone Joint Surg Br, August 1, 2005; 87-B(8): 1117 - 1122.
[Abstract] [Full Text] [PDF]



(c) British Editorial Society of Bone and Joint Surgery All Rights Reserved
Registered charity no: 209299     Print ISSN: 0301-620X
Hip, Knee, Trauma, Upper limb, Foot & Ankle, Paediatrics, Oncology, Spine, Arthroplasty, General